G1 Therapeutics (GTHX)
(Delayed Data from NSDQ)
$4.19 USD
+0.15 (3.71%)
Updated Apr 23, 2024 04:00 PM ET
After-Market: $4.19 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth C Momentum C VGM
Detailed Estimates
EPS Estimates
Earnings Date | *BMO5/1/24 |
---|---|
Current Quarter | -0.19 |
EPS Last Quarter | -0.21 |
Last EPS Surprise | 22.22% |
ABR | 2.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.64 |
Next Year | -0.26 |
EPS (TTM) | -0.95 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 15.21M | 16.35M | 68.74M | 105.25M |
# of Estimates | 4 | 4 | 4 | 4 |
High Estimate | 15.97M | 17.39M | 72.35M | 139.32M |
Low Estimate | 14.91M | 15.29M | 62.13M | 67.90M |
Year ago Sales | 12.95M | 42.39M | 82.51M | 68.74M |
Year over Year Growth Est. | 17.47% | -61.44% | -16.70% | 53.12% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.19 | -0.18 | -0.64 | -0.26 |
# of Estimates | 4 | 4 | 5 | 5 |
Most Recent Consensus | -0.20 | -0.19 | -0.67 | 0.21 |
High Estimate | -0.17 | -0.14 | -0.56 | 0.21 |
Low Estimate | -0.20 | -0.20 | -0.70 | -0.65 |
Year ago EPS | -0.53 | 0.14 | -0.93 | -0.64 |
Year over Year Growth Est. | 64.15% | -228.57% | 31.18% | 59.69% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 2 | 1 | 3 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 1 | 1 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.19 | -0.18 | -0.64 | -0.26 |
7 Days Ago | -0.19 | -0.18 | -0.64 | -0.26 |
30 Days Ago | -0.19 | -0.18 | -0.64 | -0.26 |
60 Days Ago | -0.24 | -0.17 | -0.78 | -0.35 |
90 Days Ago | -0.24 | -0.17 | -0.82 | -0.35 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.19 | -0.18 | -0.64 | -0.26 |
Zacks Consensus Estimate | -0.19 | -0.18 | -0.64 | -0.26 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.21 | -0.35 | 0.14 | -0.53 | NA |
Estimate | -0.27 | -0.31 | -0.17 | -0.64 | NA |
Difference | 0.06 | -0.04 | 0.31 | 0.11 | 0.11 |
Surprise | 22.22% | -12.90% | 182.35% | 17.19% | 52.22% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more